Robert L. Ferrara's Insider Trades & SAST Disclosures

Robert L. Ferrara's most recent trade in Phio Pharmaceuticals Corp was a trade of 23,100 Common Stock, $.0001 par value done . Disclosure was reported to the exchange on Sept. 11, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Phio Pharma Corp
Robert Ferrara L. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Sep 2025 23,100 38,766 (2%) 1% 0 Common Stock, $.0001 par value
Phio Pharma Corp
Robert L. Ferrara Director Purchase of securities on an exchange or from another person at price $ 2.42 per share. 10 Jun 2025 2,500 15,666 (0%) 0% 2.4 6,050 Common stock, $0.0001 par value
Phio Pharma Corp
Robert L. Ferrara Director Purchase of securities on an exchange or from another person at price $ 1.82 per share. 20 May 2025 2,500 13,166 (0%) 0% 1.8 4,550 Common stock, $0.0001 par value
Phio Pharma Corp
Robert L. Ferrara Director 11 Sep 2024 10,000 10,000 (0%) 0% 0 Common stock, $0.0001 par value
Phio Pharma Corp
Robert L. Ferrara Director 14 Jun 2023 2,000 6,000 (0%) 0% 3.1 6,200 Common stock, $0.0001 par value
Phio Pharma Corp
Robert L. Ferrara Director 17 Feb 2023 1,500 4,000 (0%) 0% 0 Common stock, $0.0001 par value
Phio Pharma Corp
Robert L. Ferrara Director 02 Dec 2022 5,000 30,000 (1%) 0% 0.4 2,041 Common stock, $0.0001 par value
Phio Pharma Corp
Robert L. Ferrara Director 23 Nov 2022 2,000 25,000 (1%) 0% 0.4 820 Common stock, $0.0001 par value
Phio Pharma Corp
Robert L. Ferrara Director 15 Feb 2022 10,000 23,000 (1%) 0% 0 Common stock, $0.0001 par value
Phio Pharma Corp
Robert L. Ferrara Director 01 Mar 2021 10,000 12,318 (0%) 0% 0 Common stock, $0.0001 par value
Phio Pharma Corp
Robert L. Ferrara Director 01 Mar 2021 682 13,000 (0%) 0% 3.1 2,148 Common stock, $0.0001 par value
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades